Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

Na+/K+-ATPase α3 mediates sensitivity of hepatocellular carcinoma cells to bufalin.

Li H, Wang P, Gao Y, Zhu X, Liu L, Cohen L, Meng Z, Yang P.

Oncol Rep. 2011 Mar;25(3):825-30. doi: 10.3892/or.2010.1120. Epub 2010 Dec 22.

PMID:
21181095
2.

Bufalin enhances the anti-proliferative effect of sorafenib on human hepatocellular carcinoma cells through downregulation of ERK.

Gao Y, Li HX, Xu LT, Wang P, Xu LY, Cohen L, Yang PY, Gu K, Meng ZQ.

Mol Biol Rep. 2012 Feb;39(2):1683-9. doi: 10.1007/s11033-011-0908-x. Epub 2011 May 27.

PMID:
21617941
3.

Bufalin Reverses Resistance to Sorafenib by Inhibiting Akt Activation in Hepatocellular Carcinoma: The Role of Endoplasmic Reticulum Stress.

Zhai B, Hu F, Yan H, Zhao D, Jin X, Fang T, Pan S, Sun X, Xu L.

PLoS One. 2015 Sep 18;10(9):e0138485. doi: 10.1371/journal.pone.0138485. eCollection 2015.

4.

Reversal effect of bufalin on multidrug resistance in human hepatocellular carcinoma BEL-7402/5-FU cells.

Gu W, Liu L, Fang FF, Huang F, Cheng BB, Li B.

Oncol Rep. 2014 Jan;31(1):216-22. doi: 10.3892/or.2013.2817. Epub 2013 Oct 24.

PMID:
24173654
5.
6.

Bufalin, a component in Chansu, inhibits proliferation and invasion of hepatocellular carcinoma cells.

Qiu DZ, Zhang ZJ, Wu WZ, Yang YK.

BMC Complement Altern Med. 2013 Jul 19;13:185. doi: 10.1186/1472-6882-13-185.

7.

Bufalin increases sensitivity to AKT/mTOR-induced autophagic cell death in SK-HEP-1 human hepatocellular carcinoma cells.

Tsai SC, Yang JS, Peng SF, Lu CC, Chiang JH, Chung JG, Lin MW, Lin JK, Amagaya S, Wai-Shan Chung C, Tung TT, Huang WW, Tseng MT.

Int J Oncol. 2012 Oct;41(4):1431-42. doi: 10.3892/ijo.2012.1579. Epub 2012 Jul 31.

PMID:
22858649
8.

Bufalin attenuates the stage and metastatic potential of hepatocellular carcinoma in nude mice.

Zhang ZJ, Yang YK, Wu WZ.

J Transl Med. 2014 Feb 28;12:57. doi: 10.1186/1479-5876-12-57.

9.

Involvement of Na+,K(+)-ATPase inhibition in K562 cell differentiation induced by bufalin.

Numazawa S, Shinoki MA, Ito H, Yoshida T, Kuroiwa Y.

J Cell Physiol. 1994 Jul;160(1):113-20.

PMID:
8021291
10.

A cardiotonic steroid bufalin-induced differentiation of THP-1 cells. Involvement of Na+, K(+)-ATPase inhibition in the early changes in proto-oncogene expression.

Numazawa S, Inoue N, Nakura H, Sugiyama T, Fujino E, Shinoki M, Yoshida T, Kuroiwa Y.

Biochem Pharmacol. 1996 Jul 26;52(2):321-9.

PMID:
8694857
11.

Na+/K+-ATPase α1 subunit, a novel therapeutic target for hepatocellular carcinoma.

Zhuang L, Xu L, Wang P, Jiang Y, Yong P, Zhang C, Zhang H, Meng Z, Yang P.

Oncotarget. 2015 Sep 29;6(29):28183-93. doi: 10.18632/oncotarget.4726.

12.

[Effect of Na(+)/K(+)-ATPase alpha1 siRNA and ouabain upon cell cycle in human hepatoma HepG2 cell and its mechanism].

Xu ZW, Wang FM, Xu RC, Hu WL, Chen XY.

Zhonghua Yi Xue Za Zhi. 2010 Mar 30;90(12):813-7. Chinese.

PMID:
20450619
13.

Blocking autophagy enhances the apoptosis effect of bufalin on human hepatocellular carcinoma cells through endoplasmic reticulum stress and JNK activation.

Hu F, Han J, Zhai B, Ming X, Zhuang L, Liu Y, Pan S, Liu T.

Apoptosis. 2014 Jan;19(1):210-23. doi: 10.1007/s10495-013-0914-7.

PMID:
24114361
14.

A cardiotonic steroid bufalin-like factor in human plasma induces leukemia cell differentiation.

Numazawa S, Honma Y, Yamamoto T, Yoshida T, Kuroiwa Y.

Leuk Res. 1995 Dec;19(12):945-53.

PMID:
8632664
15.

Wilms' tumor 1 gene expression in hepatocellular carcinoma promotes cell dedifferentiation and resistance to chemotherapy.

Perugorria MJ, Castillo J, Latasa MU, Goñi S, Segura V, Sangro B, Prieto J, Avila MA, Berasain C.

Cancer Res. 2009 Feb 15;69(4):1358-67. doi: 10.1158/0008-5472.CAN-08-2545. Epub 2009 Feb 3.

16.

Increase in ouabain-sensitive K+-ATPase activity in hepatocellular carcinoma by overexpression of Na+, K+-ATPase alpha 3-isoform.

Shibuya K, Fukuoka J, Fujii T, Shimoda E, Shimizu T, Sakai H, Tsukada K.

Eur J Pharmacol. 2010 Jul 25;638(1-3):42-6. doi: 10.1016/j.ejphar.2010.04.029. Epub 2010 May 3.

PMID:
20447393
17.

Suppression of Mcl-1 via RNA interference sensitizes human hepatocellular carcinoma cells towards apoptosis induction.

Schulze-Bergkamen H, Fleischer B, Schuchmann M, Weber A, Weinmann A, Krammer PH, Galle PR.

BMC Cancer. 2006 Oct 2;6:232.

18.

Regulation of expression of Na+,K+-ATPase in androgen-dependent and androgen-independent prostate cancer.

Blok LJ, Chang GT, Steenbeek-Slotboom M, van Weerden WM, Swarts HG, De Pont JJ, van Steenbrugge GJ, Brinkmann AO.

Br J Cancer. 1999 Sep;81(1):28-36.

19.

Relevance of two genes in the multidrug resistance of hepatocellular carcinoma: in vivo and clinical studies.

Sun Z, Zhao Z, Li G, Dong S, Huang Z, Ye L, Liang H, Qu J, Ai X, Zhang W, Chen X.

Tumori. 2010 Jan-Feb;96(1):90-6.

20.
Items per page

Supplemental Content

Write to the Help Desk